This week, the U.S. Department of Health and Human Services (HHS) issued the first Project BioShield contract to fund the advanced development needed to support the expanded use of an existing antibiotic...

New data presented today at ASM Microbe 2017 showed that Paratek Pharmaceuticals, Inc.’s Phase 3 antibiotic omadacycline is highly active against common bacterial pathogens in acute skin and skin structure...